Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 7/20 | 0.67 |
| ▸ | CTSK | P43235 | 7/20 | 0.66 |
| ▸ | CTSB | P07858 | 3/20 | 0.63 |
| ▸ | CTSS | P25774 | 2/20 | 0.62 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6828190 | 0.89 | CAPN1 (0.72) | CTSLCTSKCTSBCTSSCAPN1 | |
| SCHEMBL7330463 | 0.87 | CTSL (0.67) | CTSLCTSKCTSBCTSSCAPN1 | |
| SCHEMBL7953394 | 0.87 | CTSK (0.72) | CTSLCTSKCTSBCTSSCAPN1 | |
| SCHEMBL7136272 | 0.86 | CTSL (0.63) | CTSLCTSKCTSBCTSSCAPN1 | |
| SCHEMBL7764593 | 0.86 | CTSL (0.65) | CTSLCTSKCTSBCTSSCAPN1 | |
| SCHEMBL7768345 | 0.86 | CTSL (0.63) | CTSLCTSKCTSBCTSSCAPN1 | |
| SCHEMBL7304278 | 0.85 | CTSL (0.68) | CTSLCTSKCTSBCTSSCAPN1 | |
| SCHEMBL7304260 | 0.85 | CTSL (0.68) | CTSLCTSKCTSBCTSSCAPN1 | |
| SCHEMBL25406813 | 0.85 | CTSK (0.77) | CTSLCTSKCTSBCTSSCAPN1 | |
| SCHEMBL8823918 | 0.85 | CTSK (0.77) | CTSLCTSKCTSBCTSSCAPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1159260-A1 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000055124-A2 | NOVEL COMPOUNDS AND COMPOSITIONS AS PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2000-09-21 | — | — | WO | disclosed |